Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Appendix B: Recommendations and Guidelines

CDC. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2009. Available at http://www.cdc.gov/nchhstp/programintegration/docs/207181-C_NCHHSTP_PCSI%20WhitePaper-508c.pdf.

National Institute on Drug Abuse. Drug facts: nationwide trends. Available at http://www.drugabuse.gov/publications/drugfacts/nationwide-trends.

CDC. Unintentional drug poisoning in the United States. Available at http://www.cdc.gov/HomeandRecreationalSafety/pdf/poison-issue-brief.pdf.

CDC. Unintentional drug poisoning in the United States. MMWR 2010;50:300–1.

CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR 2006;55(No. RR-7).

US Department of Health and Human Services. Combating the silent epidemic of viral hepatitis: action plan for the prevention, care and treatment of viral hepatitis. Available at http://hepb.org/pdf/Viral-Hepatitis-Action-plan-2011.pdf.

White House Office of National Drug Control Policy. National drug control strategy: 2009 annual report. Available at http://www.globalsecurity.org/security/library/policy/national/ndcs2009.pdf.

White House Office of National Drug Control Policy. National drug control strategy: 2010. Available at http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/ndcs2010_0.pdf.

Substance Abuse and Mental Health Services Administration. Screening, brief intervention, and referral to treatment. Available at http://www.samhsa.gov/prevention/sbirt/SBIRTwhitepaper.pdf .

National Institute on Drug Abuse. Community-based outreach model. Available at http://archives.drugabuse.gov/CBOM/CBOM.html.

Agency for Healthcare Research and Quality. Guide to clinical preventive services, 2010–2011, section 2, infectious diseases. Available at http://www.ahrq.gov/clinic/pocketgd1011/gcp10s2b.htm.

US Preventive Services Task Force. Screening for illicit drug use. Available at http://www.uspreventiveservicestaskforce.org/uspstf/uspsdrug.htm.

CDC. Sexually transmitted diseases treatment guidelines, 2010. MMWR 2010;59(No. RR-12).

American Medical Association. Guidelines for adolescent preventive services: recommendations monograph. Available at http://www.ama-assn.org//resources/doc/ad-hlth/gapsmono.pdf.

CDC. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006;55(No. RR-14).

CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP). Part I: immunization of infants, children, and adolescents. MMWR 2005;54(No. RR-16).

CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. Part II: immunization of adults. MMWR 2006;55(No. RR-16).

CDC. Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005;54(No. RR-15).

US Preventive Services Task Force. Screening for chlamydial infection. Available at http://www.uspreventiveservicestaskforce.org/uspstf/uspschlm.htm.

US Preventive Services Task Force. Screening for gonorrhea. Available at http://www.uspreventiveservicestaskforce.org/uspstf/uspsgono.htm.

US Preventive Services Task Force. Screening for genital herpes: recommendation statement. Available at http://www.uspreventiveservicestaskforce.org/uspstf05/herpes/herpesrs.htm.

US Preventive Services Task Force. Screening for cervical cancer. Available at http://www.uspreventiveservicestaskforce.org/uspstf/uspscerv.htm.

CDC. Hepatitis B vaccine: what you need to know. Available at http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-hep-b.pdf.

CDC. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2007;56(No. RR-2).

CDC. US Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. MMWR 2002;51(No. RR-18).

National Institute on Drug Abuse. Drug facts: HIV/AIDs and drug abuse: intertwined epidemics. Available at http://www.drugabuse.gov/publications/infofacts/drug-abuse-link-to-hivaids-other-infectious-diseases.

CDC. 2009 compendium of evidence-based HIV prevention interventions. Available at http://www.cdc.gov/hiv/topics/research/prs/evidence-based-interventions.htm.

National Institute on Drug Abuse. Principles of drug addiction treatment: a research-based guide. Bethesda, MD: US Department of Health and Human Services; 1999. NIH Publication No. 99-4180. Available at http://www.drugabuse.gov/sites/default/files/podat_0.pdf.

Substance Abuse and Mental Health Services Administration. Substance abuse treatment for persons with HIV/AIDS (Treatment Improvement Protocol Series (TIP) 37). Available at http://radar.boisestate.edu/pdfs/TIP37.pdf.

CDC, Health Resources and Services Administration, National Institute on Drug Abuse, National Institutes of Health, Substance Abuse and Mental Health Services Administration. Medical advice for persons who inject illicit drugs. Available at http://cdcnpin.org/Reports/MedAdv.pdf.

CDC. Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005;54(No. RR-15).

CDC. Recommendations for partner services programs for HIV infection, syphilis, gonorrhea, and chlamydia infection. MMWR 2008;57(No. RR-9).

Substance Abuse and Mental Health Services Administration. Addressing viral hepatitis in people with substance use disorders. Available at http://blog.samhsa.gov/2012/03/02/addressing-viral-hepatitis-in-people-with-substance-use-disorder.

National Institutes of Health. Management of hepatitis C, 2002. Available at http://consensus.nih.gov/2002/2002hepatitisC2002116html.htm.

Substance Abuse and Mental Health Services Administration. Substance abuse and infectious disease: cross-training for collaborative systems of prevention, treatment, and care. Available at http://tie.samhsa.gov/topics/infectious.html.

Substance Abuse and Mental Health Services Administration. Systems integration: overview paper 7. Available at http://store.samhsa.gov/shin/content/SMA07-4295/SMA07-4295.pdf.

CDC, National Center for HIV, Viral Hepatitis, STD, and TB Prevention. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States, an NCHHSTP green paper. Atlanta, GA: US Department of Health and Human Services, CDC; 2007.

National Institute on Drug Abuse. Principles of HIV prevention in drug-using populations: a research-based guide. Publication number 02–4733. Rockville, MD: National Institutes of Health; 2002. Available at http://www.nhts.net/media/Principles%20of%20HIV%20Prevention%20(17).pdf.

CDC. Framework for program evaluation in public health. MMWR 1999;48(No. RR-11).

CDC. Practical use of program evaluation among sexually transmitted disease (STD) programs. Available at http://www.cdc.gov/std/program/pupestd.htm.

CDC. Data security and confidentiality guidelines for HIV, viral hepatitis, sexually transmitted disease, and tuberculosis programs: Standards to facilitate sharing and use of surveillance data for public health action. Available at http://www.cdc.gov/nchhstp/programintegration/docs/PCSIDataSecurityGuidelines.pdf.

CDC. Recommendations on the use of quadrivalent human papillomavirus vaccine in males—Advisory Committee on Imunization Practices (ACIP), 2011. MMWR 2011;60:1705–8.

CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR 1998;47(No. RR-19).

CDC. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR 2012;61(No. RR-4).


Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.

References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.


All MMWR HTML versions of articles are electronic conversions from typeset documents. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (http://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #